18 completed, 13 recruiting, 8 unknown, 4 terminated. 12 Phase 2, 11 Not applicable, 6 Phase 1, 1 Early Phase 1, 1 Phase 3.
Follow Thyroid Carcinoma: new trials by email Literature Review of Thyroid Carcinoma trials Research Report on Thyroid Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Cancer Dabrafenib, Trametinib, Pembrolizumab - Anaplastic Thyroid Carcinoma, Thyroid Cancer | Phase 2 | Not yet recruiting | Washington University School of Medicine | 12 | 2026-12-31 | 2026-10-21 |
| Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma CellFX nsPFA Percutaneous Electrode System - Thyroid Carcinoma | Not applicable | Recruiting | M.D. Anderson Cancer Center | 15 | 2026-02-11 | 2026-09-11 |
| Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia Gastric Cancer, Hepatic Carcinoma | Recruiting | Zhejiang University | 1200 | 2025-11-01 | 2026-01-22 | |
| Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy Thyroid Carcinoma, Pediatric Cancer | Recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2550 | 2025-07-30 | 2026-03-16 | |
| The Application of Electrical Stimulation in Postoperative Pain Management of Thyroid Surgery CMNS6-1 Electronic Acupuncture Therapeutic Apparatus - Thyroid Surgery, Electrical Stimulation | Not applicable | Recruiting | Xiaonan Huang | 668 | 2025-04-30 | 2026-08-19 |
| An International Study on Pediatric Patients With Rare Tumors. Paraganglioma/ Phaeochromocytoma, Melanoma and Other Malignant Neoplasms of Skin | Recruiting | Azienda Ospedaliera di Padova | 6250 | 2025-01-25 | 2025-07-18 | |
| OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults Olaparib, Lenvatinib, Sunitinib - Renal Cell Carcinoma, Ovarian Carcinoma | Phase 4 | Unknown | University Medical Center Groningen | 30 | 2024-05-01 | 2023-11-29 |
| Study of IK-595 in RAS- or RAF-altered Advanced Tumors IK-595 - Solid Tumor, Adult, Colorectal Cancer | Phase 1 | Terminated | Ikena Oncology | 75 | 2023-12-18 | 2025-09-19 |
| Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies S241656, FOLFOX6/FOLFOX7, FOLFIRI - Non-small Cell Lung Cancer, Histiocytic Neoplasm | Phase 1 / Phase 2 | Recruiting | Institut de Recherches Internationales Servier | 554 | 2023-04-18 | 2026-10-13 |
| CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma Contrast-enhanced Ultrasound - Thyroid Nodule, Thyroid Carcinoma | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 800 | 2023-03-18 | 2026-03-23 | |
| Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC Selpercatinib, Sodium Iodine I-131, rhTSH - Thyroid Cancer, Thyroid Carcinoma | Phase 2 | Recruiting | Massachusetts General Hospital | 30 | 2023-03-01 | 2024-12-12 |
| Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas 4 EDTA tubes of peripheral blood for Multigene analysis on ccf-DNA and ccf-RNA - Thyroid Carcinoma | Recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 10 | 2022-12-15 | 2025-03-07 | |
| European Multicenter Study on Surgical Management of Advanced Thyroid Cancer Thyroidectomy with or without lymphadenectomy or multivisceral resection - Thyroid Carcinoma, Thyroid Cancer | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 3917 | 2022-12-15 | 2023-04-04 | |
| Impact of the COVID-19 Pandemic on Surgery for Thyroid Cancer Thyroidectomy - Thyroid Carcinoma | Not applicable | Completed | University of Cagliari | 22974 | 2022-06-20 | 2022-12-15 |
| Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology Hypothyroidism, Hyperthyroidism/Thyrotoxicosis | Recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 5850 | 2021-12-30 | 2025-01-17 | |
| Optimising Molecular Radionuclide Therapy Nuclear Medicine whole-body, SPECT/CT imaging., PET/CT imaging. - Neuroendocrine Tumors, Hyperthyroidism | Completed | King's College London | 50 | 2021-12-09 | 2023-03-08 | |
| Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW Bevacizumab-IRDye800CW - Thyroid Carcinoma, Surgery | Phase 1 | Completed | University Medical Center Groningen | 20 | 2021-11-29 | 2024-08-22 |
| Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors Spartalizumab, Tislelizumab - MSI-H Colorectal Cancer, Melanoma | Phase 2 | Active not recruiting | SOLTI Breast Cancer Research Group | 184 | 2021-04-12 | 2025-03-21 |
| Function Integrity of Neck Anatomy in Thyroid Surgery Intraoperative thermal ablation - Thyroid Carcinoma, Thyroid Nodule (Benign) | Not applicable | Recruiting | Wuhan University | 1264 | 2020-12-11 | 2020-12-14 |
| Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System Artificial Tears - Thyroid Carcinoma, Radioactive Iodine Level | Phase 2 | Terminated | Vanderbilt-Ingram Cancer Center | 9 | 2020-10-05 | 2024-01-18 |
Showing 20 of 48. Sign in to see all of them.
Thyroid Neoplasms (48) · Thyroid Cancer, Papillary (5) · Thyroid Nodule (5) · Carcinoma, Medullary (4) · Cholangiocarcinoma (3) · Colorectal Neoplasms (3) · Melanoma (3) · Mesothelioma (3) · Neoplasms (3) · Pancreatic Neoplasms (3) · Anus Neoplasms (2) · Carcinoma, Hepatocellular (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (2) · Disease (2)
Endocrine Gland Neoplasms (48) · Endocrine System Diseases (48) · Neoplasms by Site (48) · Head and Neck Neoplasms (47) · Thyroid Diseases (46) · Neoplasms (45) · Neoplasms by Histologic Type (18) · Neoplasms, Glandular and Epithelial (17) · Carcinoma (15) · Adenocarcinoma (12) · Neoplasms, Germ Cell and Embryonal (10) · Neoplasms, Nerve Tissue (10) · Neuroectodermal Tumors (10) · Neuroendocrine Tumors (7) · Pathological Conditions, Signs and Symptoms (7)
Thyroidectomy (5) · Sorafenib (2) · Sunitinib (2) · Thyrotropin Alfa (2) · Vemurafenib (2) · pazopanib (2) · pembrolizumab (2) · 130-nm albumin-bound paclitaxel (1) · Blood Specimen Collection (1) · Cetuximab (1) · Coffee (1) · DEAE-Dextran (1) · Gemcitabine (1) · IFL protocol (1) · Iodine-124 (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna (3) · Memorial Sloan Kettering Cancer Center (3) · Bayer (2) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2) · University Medical Center Groningen (2) · Assistance Publique - Hôpitaux de Paris (1) · Azienda Ospedaliera di Padova (1) · Centre Leon Berard (1) · Children's Hospitals and Clinics of Minnesota (1) · Christian von Buchwald (1) · Exelixis (1) · Fujian Medical University (1) · Hannover Medical School (1) · Hutchison Medipharma Limited (1) · Ikena Oncology (1)
United States (14) · China (8) · Italy (8) · France (4) · United Kingdom (4) · Japan (3) · Denmark (2) · Germany (2) · Netherlands (2) · Spain (2) · Australia (1) · Hong Kong (1) · Romania (1) · Singapore (1) · South Korea (1)
Alain Ravaud, Pr. (1) · Alan L Ho, MD, PhD (1) · Alan L. Ho, MD, PhD (1) · Alexandru Irimie, PhD (1) · Anne Traynor, M.D. (1) · Baoming Luo, Professor (1) · Caroline Germa, MD (1) · Christian Von Buchwald, MD, DMSc (1) · Diansan Su (1) · Dorota Krajewski, MD (1) · Dr Kate Newbold (1) · Esther Broekman, MD (1)
PMID 37171634, PMID 19556464, PMID 20189981, PMID 21606412, PMID 23489023, PMID 23676418, PMID 25209242, PMID 25928353, PMID 27441995, PMID 28301826, PMID 28674120, PMID 28699990, PMID 29343557, PMID 30178239, PMID 30256977, PMID 30339877, PMID 30672147, PMID 30677214, PMID 30715996, PMID 30824630, PMID 30943124, PMID 31296931, PMID 31682550, PMID 31820118, PMID 31838154, PMID 31852120, PMID 31952842, PMID 31980466, PMID 32291395, PMID 32359091, PMID 32415267, PMID 32919526, PMID 33119505, PMID 33484847, PMID 33570641, PMID 33630087, PMID 33637876, PMID 33782093, PMID 33836153, PMID 33875804, PMID 34509954, PMID 34990208, PMID 35114169, PMID 35361487, PMID 35588692, PMID 35680043, PMID 35777186, PMID 35835611, PMID 36200668, PMID 36748723
2015 (1), 2025 (1)